CDMO services speed biologics to clinical trials faster

Deciding when outsourcing makes sense

If your business strategy doesn’t fully align with your organization’s capabilities in terms of expertise, capacity, and resources, it might be wise to consider outsourcing to a biologics CDMO for speed to market.

“To facilitate the speed of clinical process development, we had to assess how this approach would affect our project timeline and then look at strategies to shorten the R&D phase.”

Chris Rode, Scientific Director at Janssen
Pharmaceuticals/Discovery, Product Development & Supply

Contact Us

Choosing the right CDMO

Leveraging service support externally might feel risky when you want to maintain ownership and control over your process outcome, or if you need to protect your intellectual property in new markets. There are five key qualities that you should look for in your CDMO partner, three are sometimes overlooked.

Fast Trak Capabilities

Parallel operations in biopharma manufacturing

Being honest with yourself about what internal capabilities exist and whether the necessary skills and resources are available in-house to deliver on time can help avoid major failures and/or a longer lead time to market.

Read this to decide whether you should double up with a CDMO to reduce risk.

Relationship is everything

Work with a company who fills the gaps in your organization and enhances, rather than replaces, your internal expertise. Ask your CDMO if they offer:

A one team approach: allowing persons in plant
Process security: do you trust process details to be shared openly
Documentation rigor: best practices for optimal communications

Is your biologics CDMO transparent?

Deciding when outsourcing makes sense

Choosing the right CDMO

Parallel operations in biopharma manufacturing

Relationship is everything

Contact Us

Something went wrong!

Thank you!